Salute e Benessere

SS&C, U.K.'s National Health Service Shared Business Services Team Up to Deliver…

"Our thriving intelligent automation program is further enhanced by our partnership with SS&C Blue Prism, which already has a robust presence within the NHS," said James Parker, Automation Lead for NHS SBS. "The integrability of their solutions supports our NHS customers who use different automation suppliers, facilitating data interoperability to meet the needs of NHS organizations." "Our thriving intelligent automation program is further enhanced by our partnership…
PR Newswire
26/07/2023

AC Immune SA Appoints New Chief Medical Officer

AC Immune SAAppoints New Chief Medical OfficerNuno Mendonça, MD appointed new Chief Medical Officer and Executive Committee memberLausanne, Switzerland,July26 ,2023– AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced the appointment of Nuno Mendonça, MD. He will join the Company on October 1st, as Chief Medical Officer and be appointed to the Executive Committee...
Nasdaq GlobeNewswire
26/07/2023

Alkermes plc Reports Second Quarter 2023 Financial Results

— Prevailed in Janssen Arbitration; Recorded $248.4 Million in Back Royalties and Interest — —Prevailed in Janssen Arbitration; Recorded$248.4 Millionin Back Royalties and Interest — —GAAP Net Income of $237.1 Million and Non-GAAP Net Income of $94.3 Million — —Financial Expectations for Full-Year 2023 Reiterated — DUBLIN,July 26, 2023/PRNewswire/ --Alkermes plc(Nasdaq: ALKS) today reported financial results for the second quarter of 2023. "The second quarter...
PR Newswire
26/07/2023

ALSA Ventures launches Vantage Biosciences to treat Diabetic Eye Disease

Diabetic eye diseases are the leading cause of blindness in the working age population VX-01 is an oral therapy – current treatments require regular invasive intravitreal injections and intervene at advanced stages of diseaseSet to commence Phase 2 clinical trial mid-2024VX-01 targets the neurovascular inflammatory events that are believed to result in microvascular sequalae, and thus offers the promise of early intervention to modify or halt disease progression LONDON, July26, 2023...
Nasdaq GlobeNewswire
26/07/2023

Hope Vision Co., Ltd. the First Taiwanese Manufacturer to Land MDR/QMS…

Silicone hydrogel contact lenses are made from advanced polymer materials, providing superior elasticity and breathability compared to traditional hydrogel lenses. The development and manufacturing process of silicone hydrogel contact lenses require meticulous mastery of materials, processes, and technologies. Silicone hydrogel contact lenses are made from advanced polymer materials, providing superior elasticity and breathability compared to traditional hydrogel lenses. The development and...
PR Newswire
26/07/2023

ImageBiopsy Lab launches IB Lab SQUIRREL: AI-powered Assessment of Scoliosis…

Scoliosis affects millions worldwide. Precise evaluation of spine deformities is vital for treatment planning and monitoring. However, the identification of the curvature end vertebrae and the measurement of the Cobb angle are notoriously tedious and prone to high inter and intra-observer variability. Clinical evidence has revealed that measurements taken in the afternoon can show a 5° higher Mean Cobb angle compared to those taken in the morning by the same reader. To address these...
PR Newswire
26/07/2023

Medicover Interim report April-June 2023

First half First half REVENUE AND EARNINGS CEO Statement We have delivered strong organic growth in the quarter despite high market uncertainty globally. Healthcare Services delivered robust organic growth and improved margins although still with many immature units in the portfolio and Diagnostic Services replaces most of the Covid-19 revenue, with healthy underlying growth rates. In June we inaugurated a new 200 bed state-of-the-art hospital inBucharest, the first...
PR Newswire
26/07/2023

Lunit Accelerates Expansion Across Middle East by Bringing AI Solution to Dr…

Under the agreement, Lunit will supply its AI solution for mammography analysis, Lunit INSIGHT MMG, to Dr. Sulaiman Al Habib Medical Group for the next three years. HMG intends to integrate Lunit INSIGHT MMG into the diagnosis systems of medical institutions across the Middle East, analyzing hundreds of thousands of mammography images annually. Under the agreement, Lunit will supply its AI solution for mammography analysis, Lunit INSIGHT MMG, to Dr. Sulaiman Al Habib Medical Group for the…
PR Newswire
26/07/2023

CordenPharma Establishes World-Class Technology & Science Advisory Board of…

CordenPharma's TSAB brings together eight scientific experts from various disciplines, including chemistry, pharmacology, biotechnology, and regulatory affairs. CordenPharma's TSAB brings together eight scientific experts from various disciplines, including chemistry, pharmacology, biotechnology, and regulatory affairs. Their collective expertise will provide valuable insights into emerging trends, cutting-edge technologies, and regulatory advancements across all sixCordenPharma technology...
PR Newswire
26/07/2023

Neuroendocrine Tumors Market to Observe Impressive Growth by 2032, Predicts…

Key Takeaways from the Neuroendocrine Tumors Market Report Key Takeaways from the Neuroendocrine Tumors Market Report Discover which therapies are expected to grab the major neuroendocrine tumors market share @Neuroendocrine Tumors Market Report Neuroendocrine Tumors Overview Neuroendocrine tumors (NETs) are a diverse group of rare and complex tumors that arise from neuroendocrine cells. These specialized cells are found throughout the body and produce hormones, making them...
PR Newswire
25/07/2023

DBV Technologies to Report First Half 2023 Financial Results and Provide a…

DBV Technologies to ReportFirst Half 2023 Financial Results and Provide a Corporate Update DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Monday, July 31 st, at 5:00 p.m. ET to report first half 2023 financial results and provide a corporate update.Participants may access this event via the below...
Nasdaq GlobeNewswire
25/07/2023

Amarin Receives Positive Recommendation from Spanish Drug Pricing Committee for…

-- Spain's Drug Pricing Committee recommends reimbursement of VAZKEPA ®(icosapent ethyl) to reduce the risk of cardiovascular (CV) events in patients with high cardiovascular risk 1-- -- Positive recommendation marks the final step in the reimbursement process in Spain following months of active negotiations between the Spanish Ministry of Health, the regional authorities and Amarin ---- Amarin expects eligible cardiovascular patients to be able to access VAZKEPA under...
Nasdaq GlobeNewswire
25/07/2023

EssilorLuxottica to expand into the hearing solutions market with a new…

EssilorLuxottica to expand into the hearing solutions market with a new disruptivetechnology at the intersection of sight and soundSupported by proprietary hardware and software ,the Companyaims to eliminate the stigma associated with traditional hearing solutions .Charenton-le-Pont, France (July 25 , 2023 – 6:00pm CEST)– EssilorLuxottica, a global leader in the design, manufacture and distribution of advanced lens technology and iconic...
Nasdaq GlobeNewswire
25/07/2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 29 - 2023

Aggregatedpresentationbydayandbymarket NameofissuerIdentificationcodeof issuer(Legal Entity Identifier)Day of transactionIdentificationcodeof financialinstrumentAggregated daily volume(innumber of shares)Dailyweightedaveragepriceof the purchased shares *Market(MICCode) IPSEN549300M6SGDPB4Z94P1117/07/2023FR0010259150275109.76AQEUIPSEN549300M6SGDPB4Z94P1117/07/2023...
Nasdaq GlobeNewswire
25/07/2023

EssilorLuxottica: Q2/H1 2023 Results - Strong sales growth, solid margins…

Q2/H1 2023 RESULTSStrong sales growth,solid margins confirmedAll regions and segments growingOn track with carbon neutrality in Europe by end of 2023 Group's revenue up 8.0% in Q2 and 8.2% in H1 at constant exchange rates 1 EMEA double-digit up in Q2, China rebounding strongly , North AmericapositiveRetail in EMEA as a key driver , with the integration acceleratingStellest more than doubling in H1, Varilux XR ...
Nasdaq GlobeNewswire
25/07/2023

EV-based Liquid Biopsy Market worth $349.19 Million by 2031 - Exclusive Report…

Extracellular Vesicles (EVs) are released by every body cell, which is a snapshot of cellular biological activity. They can be in biofluids such as blood and provide the best way to detect and prevent non-invasive diseases, including cancer. EV-based liquid biopsy holds great promise for cancer diagnosis, prognosis and clinical monitoring. However, it is still necessary to provide precise EV subtype classification, standardized protocols, and larger patient cohort studies for further clinical…
PR Newswire
25/07/2023

Metagenomic Sequencing Market worth $4.5 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=60408643 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=60408643 Browse in-depth TOC on "Metagenomic Sequencing Market"226 - Tables44 - Figures 258 - Pages Metagenomic Sequencing Market Scope: Reagents & Consumables subsegment accounted for the largest share of the metagenomic sequencing market by product & service Among...
PR Newswire
25/07/2023

MoonLake completes patient randomization ahead of schedule for its Phase 2 trial…

MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readouts Randomization target of 200 patients completed ahead of schedule in the ARGO PsA trialTop-line 12-week results of the ARGO trial in PsA for the novel IL-17A and IL-17F inhibiting Nanobody ®sonelokimab, are now expected in the first half of November 2023, ahead of the American College of Rheumatology Conference, November...
Nasdaq GlobeNewswire
25/07/2023

HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I…

The agreement sees the HaemaLogiX and Peter Mac Centre of Excellence in Cellular Immunotherapy continue to co-develop KMA.CAR-T, following a collaborative preclinical research project that demonstrated compelling proof of concept. Preclinical data shows the anti-KMA CAR-T cells selectively killed KMA-expressing myeloma cell lines and demonstrated potent anti-myeloma activity in a xenograft mouse model. The agreement sees the HaemaLogiX and Peter Mac Centre of Excellence in Cellular...
PR Newswire
25/07/2023

Innocan Pharma Announces Private Placement of Units at a 9% Prime Above Share…

Each Class A Warrant will entitle the holder thereof to purchase one Common Share at a price of C$0.29 for a period of three (3) years from the date of issuance. Each Class B Warrant will entitle the holder thereof to purchase one Common Share at a price of C$0.40 for a period of five (5) years from the date of issuance. Each Class A Warrant will entitle the holder thereof to purchase one Common Share at a price ofC$0.29for a period of three (3) years from the date of issuance. Each Class B...
PR Newswire
25/07/2023

Cancer Diagnostics Market to be Worth $162.57 Billion by 2030: Grand View…

Read 240-page market research report, "Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 240-page market research report, " Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type…
PR Newswire
25/07/2023

Curium Announces License and Development Agreement With Lantheus for AI-Based…

Builds on existing collaboration between Curium and Lantheus for prostate cancer PSMA-targeted PET imagingDeep-learning platform for standardization of comprehensive reporting in Europe PARIS, July25, 2023(GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today a 'License and Development' agreement with EXINI Diagnostics AB, a Lantheus company (EXINI), to customize EXINI's artificial intelligence (AI) platform for use in Europe. The agreement builds on the...
Nasdaq GlobeNewswire
25/07/2023

Protein Expression Market to be Worth $6.64 Billion by 2030: Grand View…

Read 150 page market research report, "Protein Expression Market Size, Share & Trends Analysis Report By Expression System (Prokaryotic, Mammalian Cell), By Product (Reagents, Competent Cells), By Application (Therapeutic, Industrial), By End-use, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 150 page market research report, " Protein Expression Market Size, Share & Trends Analysis Report By Expression System (Prokaryotic, Mammalian Cell), By…
PR Newswire
25/07/2023

Biosimilars Market to be Worth $76.2 Billion by 2030 - Grand View Research, Inc.

Read full market research report, "Biosimilars Market Size, Share & Trends Analysis By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins), By Application (Rheumatoid Arthritis, Oncology), By Region And Segment Forecasts 2023 - 2030", published by Grand View Research. Read full market research report, " Biosimilars Market Size, Share & Trends Analysis By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins), By…
PR Newswire
25/07/2023
Altri  Comunicati